SCHEMBL19154684

SCHEMBL19154684

CCC(=O)OCc1ccc(NC(=O)OCCNC(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.46
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
HPGD P15428 3/20 0.46
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPK1 P28482 2/20 0.42
NAMPT P43490 1/20 0.42
TP53 P04637 2/20 0.41
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
CASP1 P29466 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MCL1 Q07820 1/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17448206 0.87 SMN1; SMN2 (0.45) SMN1; SMN2RAB9ANPC1L3MBTL1HPGD
SCHEMBL1755636 0.83 KMT2A (0.49) SMN1; SMN2RAB9ANPC1L3MBTL1HPGD
SCHEMBL12452413 0.77 RXFP1 (0.41) SMN1; SMN2RAB9AL3MBTL1KMT2AMEN1
SCHEMBL18556671 0.77 SLC6A2 (0.39) L3MBTL1KMT2AMEN1MAPK1MAPT
SCHEMBL20975935 0.76 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1L3MBTL1HPGD
SCHEMBL22106658 0.75 KMT2A (0.58) SMN1; SMN2RAB9AL3MBTL1HPGDKMT2A
SCHEMBL8930757 0.75 KMT2A (0.46) SMN1; SMN2RAB9AKMT2AMEN1ALDH1A1
SCHEMBL22652916 0.74 NAAA (0.45) SMN1; SMN2KMT2AMEN1ALDH1A1MAPT
SCHEMBL13755177 0.74 MAPT (0.47) SMN1; SMN2RAB9AL3MBTL1KMT2AMEN1
SCHEMBL7641621 0.72 ALDH1A1 (0.52) L3MBTL1HPGDKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170202974-A1 LINKERS AND THEIR APPLICATION TOWARDS ADC MEDSHINE DISCOVERY INC. (CN) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170202974-A1 LINKERS AND THEIR APPLICATION TOWARDS ADC DNPEP, DPP7, DPP3 SMN1; SMN2 2988/4885RAB9A 1974/4885NPC1 1216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.